Literature DB >> 500690

Human high molecular weight kininogen. Studies of structure-function relationships and of proteolysis of the molecule occurring during contact activation of plasma.

D M Kerbiriou, J H Griffin.   

Abstract

Human high Mr kininogen was purified from normal plasma in 35% yield. The purified high Mr kininogen appeared homogeneous on polyacrylamide gels in the presence of sodium dodecyl sulfate and mercaptoethanol and gave a single protein band with an apparent Mr = 110,000. Using sedimentation equilibrium techniques, the observed Mr was 108,000 +/- 2,000. Human plasma kallikrein cleaves high Mr kininogen to liberate kinin and give a kinin-free, two-chain, disulfide-linked molecule containing a heavy chain of apparent Mr = 65,000 and a light chain of apparent Mr = 44,000. The light chain is histidine-rich and exhibits a high affinity for negatively charged materials. The isolated alkylated light chain quantitatively retains the procoagulant activity of the single-chain parent molecule. 125I-Human high Mr kininogen undergoes cleavage in plasma during contact activation initiated by addition of kaolin. This cleavage, which liberates kinin and gives a two-chain, disulfide-linked molecule, is dependent upon the presence of prekallikrein and Factor XII (Hageman factor) in plasma. Addition of purified plasma kallikrein to normal plasma or to plasmas deficient in prekallikrein or Factor XII in the presence or absence of kaolin results in cleavage of high Mr kininogen and kinin formation.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 500690

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  40 in total

1.  The sequence HGLGHGHEQQHGLGHGH in the light chain of high molecular weight kininogen serves as a primary structural feature for zinc-dependent binding to an anionic surface.

Authors:  R A DeLa Cadena; R W Colman
Journal:  Protein Sci       Date:  1992-01       Impact factor: 6.725

2.  Kinetics of inhibition of platelet calpain II by human kininogens.

Authors:  H N Bradford; A H Schmaier; R W Colman
Journal:  Biochem J       Date:  1990-08-15       Impact factor: 3.857

3.  Investigation of an albumin-enriched fraction of human serum and its albuminome.

Authors:  Rebekah L Gundry; Qin Fu; Christine A Jelinek; Jennifer E Van Eyk; Robert J Cotter
Journal:  Proteomics Clin Appl       Date:  2007-01-01       Impact factor: 3.494

4.  High molecular weight kininogen is an inhibitor of platelet calpain.

Authors:  A H Schmaier; H Bradford; L D Silver; A Farber; C F Scott; D Schutsky; R W Colman
Journal:  J Clin Invest       Date:  1986-05       Impact factor: 14.808

5.  Characterization of a variant prekallikrein, prekallikrein Long Beach, from a family with mixed cross-reacting material-positive and cross-reacting material-negative prekallikrein deficiency.

Authors:  B N Bouma; D M Kerbiriou; J Baker; J H Griffin
Journal:  J Clin Invest       Date:  1986-07       Impact factor: 14.808

6.  Kallikrein-like activity of crotalase, a snake venom enzyme that clots fibrinogen.

Authors:  F S Markland; C Kettner; S Schiffman; E Shaw; S S Bajwa; K N Reddy; H Kirakossian; G B Patkos; I Theodor; H Pirkle
Journal:  Proc Natl Acad Sci U S A       Date:  1982-03       Impact factor: 11.205

7.  Guinea pig plasma kallikrein as a vascular permeability enhancement factor. Its dependence on kinin generation and regulation mechanisms in vivo.

Authors:  T Imamura; T Yamamoto; T Kambara
Journal:  Am J Pathol       Date:  1984-04       Impact factor: 4.307

8.  Kinetic analysis of the interaction of human tissue kallikrein with single-chain human high and low molecular weight kininogens.

Authors:  M Maier; K F Austen; J Spragg
Journal:  Proc Natl Acad Sci U S A       Date:  1983-07       Impact factor: 11.205

9.  A putative transmembrane protein with histidine-rich charge clusters encoded in the H-2K/tw5 region of mice.

Authors:  B St-Jacques; T H Han; A MacMurray; H S Shin
Journal:  Mol Cell Biol       Date:  1990-01       Impact factor: 4.272

10.  Immunocytochemical localization of albumin, transferrin, angiotensinogen and kininogens during the initial stages of the rat liver differentiation.

Authors:  J L Gelly; J P Richoux; G Grignon; J Bouhnik; T Baussant; F Alhenc-Gelas; P Corvol
Journal:  Histochemistry       Date:  1991
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.